Elicio Therapeutics, Inc. Annual Operating Margin in % from 2020 to 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Elicio Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2020 to 2022.
  • Elicio Therapeutics, Inc. Operating Margin for the quarter ending March 31, 2023 was -2.61K %, a 2183% decline year-over-year.
  • Elicio Therapeutics, Inc. annual Operating Margin for 2022 was -1.03K %, a 643% decline from 2021.
  • Elicio Therapeutics, Inc. annual Operating Margin for 2021 was -139 %, a 92.8% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -1.03K -893 -643% Jan 1, 2022 Dec 31, 2022
2021 -139 +1.78K +92.8% Jan 1, 2021 Dec 31, 2021
2020 -1.92K Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.